Tom Hartl

Tom Hartl has a strong background in molecular biology and genetics, with experience in conducting research at various institutions like BioMarin Pharmaceutical Inc., Stanford University, and the University of Arizona. With a Ph.D. in Molecular and Cellular Biology, Tom's work has focused on investigating rare genetic diseases and cellular signaling pathways. Tom has also utilized high throughput screening methods to discover new small molecule therapies for patients with rare diseases. Additionally, Tom has experience in genetic methods and proteomics using fruit flies and mammalian tissue cultures.